India’s NPPA Announces Retail Price Cap on 15 Formulations

April 19, 2022

On Tuesday, India’s National Pharmaceutical Pricing Authority (NPPA) announced new retail price caps on 15 formulations.  Manufacturers are to issue an updated price list to the Integrated Pharmaceutical Database Management System. The caps, decided upon during a meeting in late March, affect drugs for birth control and conditions including immune disorders and diabetes.

According to the Deccan Chronicle, “The price of Metformin (extended-release)+ Teneligliptin tablet, manufactured and marketed by Associated Biotech, Dales Laboratories, has been fixed at Rs 7.14 per tablet. Similarly, the retail price of Dapagliflozin + Metformin Hydrochloride extended-release tablet has been fixed at Rs 10.7 per tablet.”

To read more, click here.

(Source: Deccan Times, April 19th, 2022)

Share This Story!